ytom-roizen-header

EP 857 What's Multiple Myeloma?

Summary: About 30,280 people will be diagnosed with multiple myeloma this year. What is this lesser-known illness?
Air Date: 9/26/17
Duration: 12:30
Host: Michael Roizen, MD
Guest Bio: Ajai Chari, MD
Ajai-ChariAjai Chari, MD, is the Director of Clinical Research in the Multiple Myeloma Program and Associate Director of Clinical Research at Cancer Clinical Trials Office at The Tisch Cancer Institute at Mount Sinai and Associate Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai.

Dr. Chari is a Hematology/Oncology specialist in New York, New York. He attended and graduated from University Of California, Ucla School Of Medicine in 1999, having over 18 years of diverse experience, especially in Hematology/Oncology.

He is affiliated with many hospitals including Mount Sinai Hospital. Dr. Chari also cooperates with other doctors and physicians in medical groups including Icahn School Of Medicine At Mount Sinai.
    EP 857 What's Multiple Myeloma?
    About 30,280 people will be diagnosed with multiple myeloma this year. What is this lesser-known illness?

    Multiple myeloma is a cancer formed by malignant plasma cells in the bone marrow. Plasma cells help fight infections by making antibodies that recognize and attack germs. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can harm other tissues and organs, such as the kidneys.

    Dr. Adjai Chari shares the symptoms of this cancer you should know and look out for, along with the latest research on treatments and their effectiveness.
    More from this show . . .
    Prev
    Next

    EP 857 News of the WeekEP 858 News of the Week

    Comments

    FREE RadioMD Newsletter: